摘要
目的运用终末期肝病模型(MELD)评分与CTP分级等对失代偿期肝硬化患者短期生存状况进行相关性回顾性分析,预测失代偿期肝硬化患者3个月、1年的病死率。方法应用MELD、MELD—Na计算公式及CTP分级分别对119例肝硬化失代偿期患者进行评分及分级,比较不同MELD评分(≤9、10~19、20~29、≥30分)组及CTP不同分级患者(A、B、C级)3月和1年的病死率,并分析肝硬化失代偿期患者随访3月、1年预后的临床特征。结果MELD评分≤9、10~19、20.29、≥30分者,3个月内死亡率分别为:2.17%,10.71%、64.29%和100%;1年病死率分别为:26.09%、32.14%、57.14%和100%,各组间差异有显著性(3月组P〈0.05,1年组P〈0.01)。表明肝硬化失代偿期患者短期(3月与1年)病死率与MELD分值有关。以R〉18分为界分组比较3月、1年的病死率,结果显示〉18分的3月、1年病死率明显高于≤18分组,差异有极显著性(两组P〈0.01)。CTP分级显示:A、B、C级3个月内各组死亡率分别为6.78%、15.38%、42.86%,各组差异有极显著性(P〈0.01)。
Objective To retrospectively analyze the short-term survival status of decompensated hepatocirrhosis by the Model for End-Stage Liver Disease ( MELD ) and Child-Turcotte-Pugh ( CTP ) score and to predict 3-month and one-year mortality rates in decompensated hepatocirrhosis. Methods MELD, MELD-Na, and CTP score decompensated hepatocirrhosis were used to classify and graded decompensated hepatocirrhosis in 119 patients.The 3-month and one-year morality rates were compared among patients with different MELD scores ( ≤9, 10-19, 20-29, and ≥30 ) or different CTP classification ( A, B, and C ). The clinical features were analyzed in the patienes during a 3- month and a one-year follow-up. Results The 3-month mortality rate was 2.17 % for MELD ≤ 9, 10.71% for 10-19, 64.29 % for 20-29, and 100 % for I〉30; and the one-year mortality was 26.09%, 32.14%, 57.14 %, and 100 %, respectively. The short-term mortality was associated with MELD scores. If R 〉 18 was used as a standard, the 3-month and one-year mortality rates were significantly higher in the group with R 〉 18 than in the group with R= 18 ( P〈 0.01 for both comparisons ). The 3-month mortality rate was 6.78 % for CTP A, 15.38 % for B, and 42.86 % for C ( P〈 0.01 and the one-year mortality was 11.86 %, 38.46 %, and 90.48 %, respectively ( P〈 0.05 ). MELD-Na was related to the short-term mortality ( 3 months and 1 year ) in decompenated hepatocirrosis ( P 〈 0.01 ). Conclusions Both MELD and CTP scores can accurately predict the short-term prognosis in patients with decompensated hepatocirrhosis.
出处
《国际医药卫生导报》
2012年第3期333-337,共5页
International Medicine and Health Guidance News